Patents by Inventor Andrew A. Brayman

Andrew A. Brayman has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10794827
    Abstract: Embodiments are generally related to differentiating and/or separating portions of a sample that are of interest from the remainder of the sample. Embodiments may be directed towards separating cells of interest from a cell sample. In some embodiments, acoustic impedances of the cells of interest may be modified. For example, the acoustic properties of the cells of interest may be modified by attaching bubbles to the cells of interest. The cell sample may then be subjected to an acoustic wave. The cells of interest may be differentiated and/or separated from the remainder of the sample based on relative displacements and/or volumetric changes experienced by the cells of interest in response thereto. The cells of interest may be separated using a standing wave and sorted into separate channels of a flow cell. Optionally, the cells may be interrogated by a light source and differentiated by signals generated in response thereto.
    Type: Grant
    Filed: April 4, 2017
    Date of Patent: October 6, 2020
    Assignee: UNIVERSITY OF WASHINGTON
    Inventors: Thomas Matula, Andrew A. Brayman, Oleg A. Sapozhnikov, Brian MacConaghy, Jarred Egan Swalwell, Camilo Perez
  • Publication number: 20170328834
    Abstract: Embodiments are generally related to differentiating and/or separating portions of a sample that are of interest from the remainder of the sample. Embodiments may be directed towards separating cells of interest from a cell sample. In some embodiments, acoustic impedances of the cells of interest may be modified. For example, the acoustic properties of the cells of interest may be modified by attaching bubbles to the cells of interest. The cell sample may then be subjected to an acoustic wave. The cells of interest may be differentiated and/or separated from the remainder of the sample based on relative displacements and/or volumetric changes experienced by the cells of interest in response thereto. The cells of interest may be separated using a standing wave and sorted into separate channels of a flow cell. Optionally, the cells may be interrogated by a light source and differentiated by signals generated in response thereto.
    Type: Application
    Filed: April 4, 2017
    Publication date: November 16, 2017
    Applicant: University of Washington
    Inventors: Thomas Matula, Andrew A. Brayman, Oleg A. Sapozhnikov, Brian MacConaghy, Jarred Egan Swalwell, Camilo Perez
  • Patent number: 9645080
    Abstract: Embodiments are generally related to differentiating and/or separating portions of a sample that are of interest from the remainder of the sample. Embodiments may be directed towards separating cells of interest from a cell sample. In some embodiments, acoustic impedances of the cells of interest may be modified. For example, the acoustic properties of the cells of interest may be modified by attaching bubbles to the cells of interest. The cell sample may then be subjected to an acoustic wave. The cells of interest may be differentiated and/or separated from the remainder of the sample based on relative displacements and/or volumetric changes experienced by the cells of interest in response thereto. The cells of interest may be separated using a standing wave and sorted into separate channels of a flow cell. Optionally, the cells may be interrogated by a light source and differentiated by signals generated in response thereto.
    Type: Grant
    Filed: April 16, 2014
    Date of Patent: May 9, 2017
    Assignee: University of Washington
    Inventors: Thomas Matula, Andrew A. Brayman, Oleg A. Sapozhnikov, Brian MacConaghy, Jarred Egan Swalwell, Camilo Perez
  • Publication number: 20150017678
    Abstract: Embodiments are generally related to differentiating and/or separating portions of a sample that are of interest from the remainder of the sample. Embodiments may be directed towards separating cells of interest from a cell sample. In some embodiments, acoustic impedances of the cells of interest may be modified. For example, the acoustic properties of the cells of interest may be modified by attaching bubbles to the cells of interest. The cell sample may then be subjected to an acoustic wave. The cells of interest may be differentiated and/or separated from the remainder of the sample based on relative displacements and/or volumetric changes experienced by the cells of interest in response thereto. The cells of interest may be separated using a standing wave and sorted into separate channels of a flow cell. Optionally, the cells may be interrogated by a light source and differentiated by signals generated in response thereto.
    Type: Application
    Filed: April 16, 2014
    Publication date: January 15, 2015
    Applicant: University of Washington Through Its Center for Commercialization
    Inventors: Thomas Matula, Andrew A. Brayman, Oleg A. Sapozhnikov, Brian MacConaghy
  • Publication number: 20110288410
    Abstract: Methods and systems for monitoring the progress of high intensity focused ultrasound (HIFU) therapy use diagnostic ultrasound to identify temperature differentials using scatterer tracking between two backscattered radio frequency frames. The observed displacement of the scatterers may be combined with knowledge of the exposure protocol, material properties, heat transfer, and/or measurement noise to estimate heating, thermal dose, and temperature conditions resulting from the HIFU therapy.
    Type: Application
    Filed: February 22, 2011
    Publication date: November 24, 2011
    Inventors: Gavriel A. Speyer, Andrew A. Brayman, Lawrence A. Crum, Peter J. Kaczkowski
  • Patent number: 7591996
    Abstract: Selective occlusion of a blood vessel is achieved by selectively damaging endothelial cells at a target location in the blood vessel, resulting in the formation of a fibrin clot proximate to the damaged endothelial cells. Additional fibrinogen can then be introduced into the blood vessel if occlusion is not achieved, as the fibrinogen is converted to fibrin by enzymes released by the exposed thrombogenic tissue and activated platelets. Endothelial cells are selectively damaged using thermal effects induced by ultrasound, by mechanical effects induced by ultrasound, or by mechanical effects produced by a tool introduced into the blood vessel (such as a catheter-based tool). A particularly preferred technique for selectively damaging endothelial cells involves introducing an ultrasound activatable agent into the blood vessel, and causing cavitation in that agent using pulses of high-intensity focused ultrasound having a duration insufficient to induce thermal damage in adjacent perivascular tissue.
    Type: Grant
    Filed: August 17, 2005
    Date of Patent: September 22, 2009
    Assignee: University of Washington
    Inventors: Joo Ha Hwang, Andrew Brayman
  • Publication number: 20070041961
    Abstract: Selective occlusion of a blood vessel is achieved by selectively damaging endothelial cells at a target location in the blood vessel, resulting in the formation of a fibrin clot proximate to the damaged endothelial cells. Additional fibrinogen can then be introduced into the blood vessel if occlusion is not achieved, as the fibrinogen is converted to fibrin by enzymes released by the exposed thrombogenic tissue and activated platelets. Endothelial cells are selectively damaged using thermal effects induced by ultrasound, by mechanical effects induced by ultrasound, or by mechanical effects produced by a tool introduced into the blood vessel (such as a catheter-based tool). A particularly preferred technique for selectively damaging endothelial cells involves introducing an ultrasound activatable agent into the blood vessel, and causing cavitation in that agent using pulses of high-intensity focused ultrasound having a duration insufficient to induce thermal damage in adjacent perivascular tissue.
    Type: Application
    Filed: August 17, 2005
    Publication date: February 22, 2007
    Applicant: University of Washington
    Inventors: Joo Hwang, Andrew Brayman